Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Chloe I Bloom, SL Elkin & JK Quint. (2019) Changes in COPD inhaler prescriptions in the United Kingdom, 2000 to 2016. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 279-287.
Read now
Read now
Ioanna Tsiligianni, Maria Kampouraki, Despo Ierodiakonou, Ioannis Poulonirakis & Polyvios Papadokostakis. (2019) COPD patients’ characteristics, usual care, and adherence to guidelines: the Greek UNLOCK study. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 547-556.
Read now
Read now
Vladimir Arkhipov, Daria Arkhipova, Marc Miravitlles, Andrey Lazarev & Ekaterina Stukalina. (2017) Characteristics of COPD patients according to GOLD classification and clinical phenotypes in the Russian Federation: the SUPPORT trial. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 3255-3262.
Read now
Read now
Mario Cazzola, Paola Rogliani, Josuel Ora & Maria Gabriella Matera. (2015) Olodaterol + tiotropium bromide for the treatment of chronic obstructive pulmonary disease. Expert Review of Clinical Pharmacology 8:5, pages 529-539.
Read now
Read now
Mireia Raluy-Callado, Dimitra Lambrelli, Sharon MacLachlan & Javaria Mona Khalid. (2015) Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 925-937.
Read now
Read now
Articles from other publishers (13)
Mònica Monteagudo, Miriam Barrecheguren, Iryna Solntseva, Nafeesa Dhalwani, Alison Booth, Alexa Nuñez, Dimitra Lambrelli & Marc Miravitlles. (2021) Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD. npj Primary Care Respiratory Medicine 31:1.
Crossref
Crossref
Olorunfemi A. Oshagbemi, Frits M.E. Franssen, Emiel F.M. Wouters, Anke H. Maitland-van der Zee, Johanna H.M. Driessen, Anthonius de Boer & Frank de Vries. (2020) C-reactive protein as a biomarker of response to inhaled corticosteroids among patients with COPD. Pulmonary Pharmacology & Therapeutics 60, pages 101870.
Crossref
Crossref
Miriam Barrecheguren, Cruz González & Marc Miravitlles. (2018) What have we learned from observational studies and clinical trials of mild to moderate COPD?. Respiratory Research 19:1.
Crossref
Crossref
Olorunfemi A. Oshagbemi, Spencer J. Keene, Johanna H.M. Driessen, Rachel Jordan, Emiel F.M. Wouters, Anthonius de Boer, Frank de Vries & Frits M.E. Franssen. (2018) Trends in moderate and severe exacerbations among COPD patients in the UK from 2005 to 2013. Respiratory Medicine 144, pages 1-6.
Crossref
Crossref
Olorunfemi A. Oshagbemi, Frits M.E. Franssen, Dionne C.W. Braeken, Yvonne Henskens, Emiel F.M. Wouters, Anke-Hilse Maitland-van der Zee, Andrea M. Burden & Frank de Vries. (2018) Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality. Pharmacoepidemiology and Drug Safety 27:11, pages 1191-1199.
Crossref
Crossref
Lianne Parkin, Wayne Khuu, Matthew B. Stanbrook, Mina Tadrous, Diana Martins & Tara Gomes. (2018) Trends in the utilisation of COPD therapeutic regimens before and after the introduction of LAMA/LABA combination products: A population-based study. Respiratory Medicine 143, pages 1-7.
Crossref
Crossref
Lianne Parkin, David Barson, Jiaxu Zeng, Simon Horsburgh, Katrina Sharples & Jack Dummer. (2017) Patterns of use of long‐acting bronchodilators in patients with COPD: A nationwide follow‐up study of new users in New Zealand. Respirology 23:6, pages 583-592.
Crossref
Crossref
Chen Hsing Lin, Sultan Alandijani & Seong H. Cho. 2018. Severe Asthma. Severe Asthma
13
34
.
Marie-Line Gentil, Marc Cuggia, Laure Fiquet, Camille Hagenbourger, Thomas Le Berre, Agnès Banâtre, Eric Renault, Guillaume Bouzille & Anthony Chapron. (2017) Factors influencing the development of primary care data collection projects from electronic health records: a systematic review of the literature. BMC Medical Informatics and Decision Making 17:1.
Crossref
Crossref
Maria Montes de Oca, Maria Victorina Lopez Varela, Maria E. Laucho-Contreras, Alejandro Casas, Eduardo Schiavi & Juan Carlos Mora. (2017) Asthma–COPD overlap syndrome (ACOS) in primary care of four Latin America countries: the PUMA study. BMC Pulmonary Medicine 17:1.
Crossref
Crossref
MeiLan K Han, Carlos H Martinez, David H Au, Jean Bourbeau, Cynthia M Boyd, Richard Branson, Gerard J Criner, Ravi Kalhan, Thomas J Kallstrom, Angela King, Jerry A Krishnan, Suzanne C Lareau, Todd A Lee, Kathleen Lindell, David M Mannino, Fernando J Martinez, Catherine Meldrum, Valerie G Press, Byron Thomashow, Laura Tycon, Jamie Lamson Sullivan, John Walsh, Kevin C Wilson, Jean Wright, Barbara Yawn, Patrick M Zueger, Surya P Bhatt & Mark T Dransfield. (2016) Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective. The Lancet Respiratory Medicine 4:6, pages 473-526.
Crossref
Crossref
Miriam Barrecheguren, Mónica Monteagudo, Jaume Ferrer, Eulalia Borrell, Carl Llor, Cristina Esquinas & Marc Miravitlles. (2016) Treatment patterns in COPD patients newly diagnosed in primary care. A population-based study. Respiratory Medicine 111, pages 47-53.
Crossref
Crossref
Keele E. Wurst, Kaitlin Kelly-Reif, Greta A. Bushnell, Steven Pascoe & Neil Barnes. (2016) Understanding asthma-chronic obstructive pulmonary disease overlap syndrome. Respiratory Medicine 110, pages 1-11.
Crossref
Crossref